<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Infinity Pharmaceuticals Inc. | Company News & Executive Profiles - INFI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/infinity+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Infinity Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="1" found="1" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Biotechnology Winners Show Investors Big Potential.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200311/ai_n22022696]]></link>
		<description><![CDATA[By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business  News    Nov. 10--In the hot area of biotechnology investment, the chief   recipients of venture capital in the third quarter would seem at first  to have  little in common.    For instance,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/boston+globe.html"><![CDATA[Boston Globe]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/infinity+pharmaceuticals+inc..html"><![CDATA[Infinity Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INFI</category>
		<category domain="tickers">INFI</category>
	</item>
</channel>
</rss>
